MedPath

Nalfon

These highlights do not include all the information needed to use NALFON safely and effectively. See full prescribing information for NALFON. NALFON (fenoprofen calcium, USP) capsules, for oral use Initial U.S. Approval: 1982

Approved
Approval ID

0cd15e8f-e9a1-4e88-a6f2-80b20e4a0e79

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 15, 2021

Manufacturers
FDA

Quality Care Products, LLC

DUNS: 831276758

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

fenoprofen calcium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55700-853
Application NumberNDA017604
Product Classification
M
Marketing Category
C73594
G
Generic Name
fenoprofen calcium
Product Specifications
Route of AdministrationORAL
Effective DateMarch 31, 2020
FDA Product Classification

INGREDIENTS (11)

CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
FENOPROFEN CALCIUMActive
Quantity: 400 mg in 1 1
Code: 0X2CW1QABJ
Classification: ACTIM
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Nalfon - FDA Drug Approval Details